Back to Journals » OncoTargets and Therapy » Volume 7

Review

Clinical response to sunitinib as a multitargeted tyrosine-kinase inhibitor (TKI) in solid cancers: a review of clinical trials

       
Total article views   HTML views PDF downloads Totals
13,357 Dovepress* 10,858+ 2,284 13,142
PubMed Central* 2,499 890 3,389
Totals 13,357 3,174 16,531
*Since 12 May 2014
+Since July 2016

View citations on PubMed Central and Google Scholar